Envoy Medical, Inc.
COCH
$0.68
$0.000.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 78.57% | -46.15% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 78.57% | -46.15% | |||
| Cost of Revenue | -89.66% | -13.25% | |||
| Gross Profit | 133.54% | -3.21% | |||
| SG&A Expenses | -40.43% | 17.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.04% | 11.69% | |||
| Operating Income | -8.53% | -12.58% | |||
| Income Before Tax | -1.60% | -13.92% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.60% | -13.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.60% | -13.92% | |||
| EBIT | -8.53% | -12.58% | |||
| EBITDA | -8.58% | -12.98% | |||
| EPS Basic | 23.33% | -9.21% | |||
| Normalized Basic EPS | 24.27% | -11.49% | |||
| EPS Diluted | 23.33% | -9.21% | |||
| Normalized Diluted EPS | 24.27% | -11.49% | |||
| Average Basic Shares Outstanding | 30.29% | 2.19% | |||
| Average Diluted Shares Outstanding | 30.29% | 2.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | 1.00% | |||